Compared with the normal tissues, higher expression of CD93 was observed in Bladder urothelial carcinoma (BLCA), Breast invasive carcinoma (BRCA), Cervical squamous cell carcinoma, and endocervical adenocarcinoma (CESC), Cholangiocarcinoma (CHOL), Colon adenocarcinoma (COAD), Kidney Chromophobe (KICH), Kidney renal papillary cell carcinoma (KIRP), Liver hepatocellular carcinoma (LIHC), Lung adenocarcinoma (LUAD), Lung squamous cell carcinoma (LUSC), Stomach adenocarcinoma (STAD), and Uterine Corpus Endometrial Carcinoma (UCEC). This evidence concerns the gene CD93 and chromophobe renal cell carcinoma.